Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

Abstract

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease (Original Article, N Engl J Med 2019;381:1103-1113). In the Secondary End Points subsection of Results (page 1108), a value given in the final sentence of the first paragraph was incorrect. The sentence should have read, “The most frequent causes of death were heart failure (6 patients in the monotherapy group and 10 in the combination-therapy group), stroke (2 vs. 9 patients), and cancer (6 vs. 13 patients),” rather than “… stroke (2 vs. 10 patients), and cancer (6 vs. 13 patients).” Table S7 in the Supplementary Appendix was also affected. The article is correct and the Supplementary Appendix has been replaced at NEJM.org.